Piramal Healthcare invests 2 million pounds in Scottish plant

18 Nov 2015 Evaluate

In a bid to expand its manufacturing plant in Scotland, Piramal Healthcare has invested two million pounds. The company is aiming to expand this facility in the next 5 years to maintain its position as a global leader in the production of antibody drug conjugates.

The plant manufactures anti-cancer drugs (antibody drug conjugates) for export. The investment of two million pounds into Scotland will yield additional revenue of 3-5 million pounds over five years to Piramal Healthcare’s revenue.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Healthcare, Healthcare Information Management and Financial Services. Its consolidated revenues were over $830 million in FY2015, with approx. 70% of revenues from outside India.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 997.60
Shriram Finance 955.35
Aditya Birla Capital 346.80
Chola Invest & Fin. 1698.35
Tata Capital 337.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×